Membranous nephropathy (MN) is a glomerular disease that can occur at all ages. In adults,
it is the most frequent cause of nephrotic syndrome. In~ 80% of patients, there is no …

Congenital nephrotic syndrome (CNS) is a heterogeneous group of disorders characterized
by nephrotic-range proteinuria, hypoalbuminaemia and oedema, which manifest in utero or …

Glomerular disease, be it primary or secondary, occurring in the setting of systemic
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …

Introduction Nephrotic syndrome is associated with an increased risk of venous and arterial
thromboembolism, which can be as high as 40% depending on the severity and underlying …

The anticoagulation field is experiencing a renaissance that began with regulatory approval
of the direct thrombin inhibitor dabigatran, a direct oral anticoagulant (DOAC), in 2010. The …

Membranous nephropathy (MN), an autoimmune disease, can manifest at any age and is
among the most common causes of nephrotic syndrome in adults. In 80% of cases, the …

Clinically apparent venous thromboembolism (VTE) occurs in approximately 7% of patients
with membranous nephropathy. Hypoalbuminemia at diagnosis is an independent risk factor …

Context: Patients with membranous nephropathy (MN) are recognized as individuals with
high risk of thrombosis. However, prophylactic anticoagulant therapy in this population is still …

Background: Evidence supporting venous thromboembolism (VTE) prophylaxis with direct
oral anticoagulants (DOACs) in patients with nephrotic syndrome (NS) is limited to case …

Background It has been recognized that primary membranous nephropathy (MN) is related
to an increased risk for thromboembolic complications. However, the current evidence …